Je was op zoek naar: rraportati (Maltees - Engels)

effetti sekondarji rraportati b’suboxone
side effects reported with suboxone

tabella 1: reazzjonijiet avversi rraportati fi provi kliniċi
table 1: adverse reactions reported in clinical trials

mill-2005 s’issa kienu rraportati 115-il sostanza.
115 such substances were reported since 2005.

tabella 1: reazzjonijiet avversi b'galafold rraportati fi provi kliniċi
table 1: adverse reactions with galafold in clinical trials

reazzjonijiet avversi rraportati f’ studji kkontrollati ta ’ fażi 3 fit- tul1
adverse reactions reported in long term phase 3 controlled studies1

generalment hemm data kwantitattiva u informazzjoni kwalitattiva insufficjenti rraportati biex ikun hemm bażi ghal evalwazzjoni komprensiva tal-politiki ambjentali.
there is generally insufficient quantitative data and qualitative information reported to underpin comprehensive evaluation of environmental policies.

il-mogħdija jew il-mogħdijiet tad-degradazzjoni iridu jiġu rraportati għal tip wieħed ta' ħamrija.
the degradation pathway or pathways must be reported for one soil.

kienu rraportati żewġ fatalitajiet fl-ue li fihom il-mephedrone tidher li kienet l-unika kawża tal-mewt.
two fatalities have been reported in the eu in which mephedrone appears to be the sole cause of death.

il-karatteristiċi mekkaniċi attwali tal-ligi għandhom jiġu rraportati, flimkien mal-ħtiġiet minimi tal-karatterstika mekkanika.
the actual mechanical properties of the alloy must be reported, together with the minimum mechanical property requirements.

għal-lista sħiħa tal-effetti sekondarji kollha rraportati b’arepanrix, ara l-fuljett ta’ tagħrif.
for the full list of all side effects reported with arepanrix, see the package leaflet.

effetti sekondarji komuni rraportati f’ aktar minn pazjent wieħed f’ kull 100, imma inqas minn wieħed f’ kull għaxra li qed jirċievu relistor huma:
common side effects reported in more than one in 100 patients, but in less than one in ten patients receiving relistor are:

l- aktar effetti mhux mixtieqa li kienu rraportati ta ’ spiss, kienu sintomi gastrointestinali bħal uġigħ addominali, dijarea, ippurgar maħlul, dardir u rimettar.
in the majority of studies adverse events were assessed by passive surveillance.

rekwiżiti (trimestrali) indirizzati lill-ifs bir-regolament (ke) nru 958/2007 (bĊe/2007/8), li jiġu rraportati lill-mmfs bħala partiti memo jekk huma disponibbli fil-bĊni.
(quarterly) requirements addressed to ifs by regulation (ec) no 958/2007 (ecb/2007/8), to be reported for mmfs as memo items if available at ncbs.